benzocaine 200 MG/ML / resorcinol 30 MG/ML [Vagisil Original Formula]
- RxCUI
- 1247438
- RxNorm name
- benzocaine 200 MG/ML / resorcinol 30 MG/ML [Vagisil Original Formula]
- Term type
- SBDC
- Status
- Active
- Updated
- 2026-06-06 07:16:22
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042012
- Active start
- 042012
- Multiple ingredient
- YES
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| 200 MG / 1 ML | benzocaine | ||
| 30 MG / 1 ML | resorcinol |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| benzocaine | 1399 |
| resorcinol | 35382 |
Source Vocabulary Codes#
| Code type | Value | Category |
|---|---|---|
| PRESCRIBABLE | Y | ATTRIBUTES |
| RXNAV_STR | benzocaine 200 MG/ML / resorcinol 30 MG/ML [Vagisil Original Formula] | NAMES |
| RxNorm Name | benzocaine 200 MG/ML / resorcinol 30 MG/ML [Vagisil Original Formula] | NAMES |
| TTY | SBDC | ATTRIBUTES |
| RxCUI | 1247438 | CODES |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | D04AB | Anesthetics for topical use | ATC1-4 | benzocaine | |
| ATC | R02AD | Anesthetics, local | ATC1-4 | benzocaine | |
| ATC | N01BA | Esters of aminobenzoic acid | ATC1-4 | benzocaine | |
| ATC | C05AD | Local anesthetics | ATC1-4 | benzocaine | |
| ATC | D10AX | Other anti-acne preparations for topical use | ATC1-4 | resorcinol | |
| ATC | S01AX | Other antiinfectives | ATC1-4 | resorcinol | |
| FDASPL | N0000185508 | Standardized Chemical Allergen | EPC | has_epc | benzocaine |
| FDASPL | N0000184306 | Cell-mediated Immunity | PE | has_pe | benzocaine |
| FDASPL | N0000175629 | Increased Histamine Release | PE | has_pe | benzocaine |
| MEDRT | D001566 | Benzocaine | CHEM | has_ingredient | benzocaine |
| MEDRT | D012118 | Resorcinols | CHEM | has_ingredient | resorcinol |
| MEDRT | D000152 | Acne Vulgaris | DISEASE | may_treat | resorcinol |
| MEDRT | D001424 | Bacterial Infections | DISEASE | ci_with | benzocaine |
| MEDRT | D002056 | Burns | DISEASE | may_treat | benzocaine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | resorcinol |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | benzocaine |
| MEDRT | D004433 | Earache | DISEASE | may_treat | benzocaine |
| MEDRT | D005401 | Fissure in Ano | DISEASE | may_treat | benzocaine |
| MEDRT | D006484 | Hemorrhoids | DISEASE | may_treat | benzocaine |
| MEDRT | D006561 | Herpes Simplex | DISEASE | may_treat | benzocaine |
| MEDRT | D019226 | Oral Ulcer | DISEASE | may_treat | benzocaine |
| MEDRT | D010032 | Otitis Externa | DISEASE | may_treat | benzocaine |
| MEDRT | D010033 | Otitis Media | DISEASE | may_treat | benzocaine |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | benzocaine |
| MEDRT | D011537 | Pruritus | DISEASE | may_treat | benzocaine |
| MEDRT | D012393 | Rosacea | DISEASE | may_treat | resorcinol |
| MEDRT | D014098 | Toothache | DISEASE | may_treat | benzocaine |
| MEDRT | N0000000223 | Mechanism of Action | MOA | has_moa | resorcinol |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | benzocaine |
| MEDRT | N0000009982 | Decreased Sebaceous Gland Activity | PE | has_pe | resorcinol |
| MEDRT | N0000008889 | Decreased Sensory-Somatic Nervous System Organized Electrical Activity | PE | has_pe | benzocaine |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | PRESCRIBABLE | Y |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | TTY | SBDC |
| CODES | RxCUI | 1247438 |
| NAMES | RXNAV_STR | benzocaine 200 MG/ML / resorcinol 30 MG/ML [Vagisil Original Formula] |
| NAMES | RxNorm Name | benzocaine 200 MG/ML / resorcinol 30 MG/ML [Vagisil Original Formula] |